Piper Sandler analyst Adam Maeder upgraded shares of Nevro Corp (NYSE:NVRO), a medical device company with a market ...
Piper Sandler (PIPR) announced that its board of directors has authorized the repurchase of up to $150 million of the company’s outstanding ...
Piper Sandler analyst Adam Maeder upgraded Nevro (NVRO) to Neutral from Underweight with a price target of $5.85, down from $6, after the company ...
Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional ...
Piper Sandler raised the firm’s price target on Kemper (KMPR) to $86 from $83 and keeps an Overweight rating on the shares following quarterly ...
Piper Sandler Companies (NYSE: PIPR), a leading investment bank, announced today that its board of directors has authorized the repurchase of up to $150 million of the company's outstanding common ...
He noted that advisory services accounted for over half of firmwide net revenues for the fourth consecutive year. Abraham stated that the company completed the acquisition of Aviditi Advisors, ...
Piper Sandler's research dated Feb. 4 has revealed a less optimistic outlook for Meta Platforms' position in the artificial intelligence race.